David A. Ramsay
2009
In 2009, David A. Ramsay earned a total compensation of $437.3K as Vice President Corporate Development at Halozyme Therapeutics, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $54,000 |
|---|---|
| Option Awards | $105,567 |
| Salary | $270,000 |
| Other | $7,746 |
| Total | $437,313 |
Ramsay received $270K in salary, accounting for 62% of the total pay in 2009.
Ramsay also received $54K in non-equity incentive plan, $105.6K in option awards and $7.7K in other compensation.
Rankings
In 2009, David A. Ramsay's compensation ranked 7,300th out of 9,885 executives tracked by ExecPay. In other words, Ramsay earned more than 26.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,300 out of 9,885 | 26th |
Division Manufacturing | 2,711 out of 3,690 | 27th |
Major group Chemicals And Allied Products | 613 out of 871 | 30th |
Industry group Drugs | 431 out of 643 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 84 out of 138 | 39th |
Source: SEC filing on April 1, 2010.
Ramsay's colleagues
We found eight more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2009.
2009
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2009
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2009
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2009
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2009
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2009
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2009
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2009
Michael LaBarre
Halozyme Therapeutics